section name header

Indications

REMS


Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: ARTERIAL/VENOUS THROMBOEMBOLISM, DISSEMINATED INTRAVASCULAR COAGULATION, hypertension, hypotension, tachycardia

GI: nausea/vomiting

MS: arthralgis

Neuro: headache, mental status changes

Misc: hypersensitivity reactions including anaphylaxis, transmission of infectious agents

Interactions

Drug-drug:

Availability

Route/Dosage

US Brand Names

Kcentra

Action

  • Replaces clotting factors (II, VII, IX, X and antithrombotic proteins C and S) which have become deficient as a result of warfarin.
Therapeutic effects:
  • Cessation of bleeding due to warfarin

Classifications

Therapeutic Classification: antidotes

Pharmacologic Classification: clotting factors replacements

Pharmacokinetics

Absorption: IV administration results in complete bioavailability.

Distribution: Rapidly distributed

Metabolism/Excretion: Utilized in reversal of bleeding

Half-Life: Factor II: 59.7 hr; Factor VII: 4.2 hr; Factor IX: 16.7 hr; Factor X: 30.7 hr;

Canadian Brand Names

Octaplex

Time/Action Profile

(reversal of warfarin effects)

ROUTEONSETPEAKDURATION
IVrapidunkat least 24 hr



Patient/Family Teaching

Pronunciation

pro-THROM-bin COM-plex KON-sen-trayt